Search - tctmd.com

Displaying 121 - 140 of 171

Sort: Relevancy | Date

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

News Daily News

Lotus Valve’s Return to Market in Europe Sees Further Delays

Shelley Wood

November 29, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

Presentation TCT 2017

PFO Closure for Hypoxemia: Who Responds and Who Does Not? Designing a Trial to Prove the Concept

Presenter: Mark Reisman, Brian K. Whisenant, Joseph Kay

November 01, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

News Conference News TCT 2017

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Yael L. Maxwell

October 31, 2017

Presentation PCR London Valves 2017

Influence of Gender on Clinical Outcomes Following TAVI with a Retrievable and Fully Repositionable Aortic Valve

Presenter: Anna-Sonio Petronio

September 25, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Daily News

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Yael L. Maxwell

April 14, 2017

News Features

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Caitlin E. Cox

March 31, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

Advertisement

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

TCTMD’s Top 10 Most Popular Stories for September 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Novel LAA Closure Device Shows Promise in Early Experience

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Lotus Valve’s Return to Market in Europe Sees Further Delays

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

PFO Closure for Hypoxemia: Who Responds and Who Does Not? Designing a Trial to Prove the Concept

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Novel Percutaneous Suture-Based Solution for PFO Closure Shows Promise

Influence of Gender on Clinical Outcomes Following TAVI with a Retrievable and Fully Repositionable Aortic Valve

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content